Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06506227
NA

Research on Key Technologies for Risk Prediction and Precise Diagnosis and Treatment of AIS Based on Epigene-phenotype

Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University

View on ClinicalTrials.gov

Summary

Mining AIS biomarkers, elucidating the new mechanism of AIS pathogenicity, constructing risk prediction models, optimizing AIS precise diagnosis and treatment techniques, formulating precise diagnosis and treatment protocols and technical specifications for AIS combined with Chinese and Western medicine with independent intellectual property rights, and realizing the full coverage of Zhejiang Province by the end of 2026, so as to form the "Zhejiang experience" of AIS diagnosis and treatment.

Official title: Research on Key Technologies for Risk Prediction and Precise Diagnosis and Treatment of Adolescent Idiopathic Scoliosis Based on Epigene-phenotype

Key Details

Gender

All

Age Range

10 Years - 18 Years

Study Type

INTERVENTIONAL

Enrollment

2000

Start Date

2024-09-01

Completion Date

2026-12-31

Last Updated

2024-07-17

Healthy Volunteers

Yes

Interventions

BEHAVIORAL

Low risk experimental group

Guiding + Manipulation + Traditional Chinese Medicine

BEHAVIORAL

Medium risk experimental group

Guiding + Manipulation + Traditional Chinese Medicine + Specific Exercise Therapy + Orthopedic Braces

GENETIC

High risk experimental group

Guiding + Manipulation + Traditional Chinese Medicine + Specific Exercise Therapy + Orthopedic Braces + Specialized Inpatient Rehabilitation

BEHAVIORAL

Control group COBB 10-20°

Specific Exercise Therapy

BEHAVIORAL

Control group COBB 20-45°

Orthopedic Braces + Specific Exercise Therapy

BEHAVIORAL

Control group COBB >45°

Orthopedic Braces + Specific Exercise Therapy + Recommended Surgery

OTHER

Experimental group (AIS group)

Molecular marker exploration and validation

OTHER

Control group (healthy control)

Molecular marker exploration and validation

OTHER

Controlled follow-up before and after AIS

Construction and validation of AIS risk prediction model completed

Locations (1)

Prokin balance apparatus

Hangzhou, Zhejiang, China